IFM Investors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Buy
35,839
+2,319
+7% +$980K 0.09% 204
2026
Q1
$15.9M Sell
33,520
-301
-0.9% -$152K 0.13% 147
2025
Q4
$15.8M Sell
33,821
-2,548
-7% -$1.18M 0.13% 134
2025
Q3
$15.2M Sell
36,369
-1,008
-3% -$391K 0.13% 137
2025
Q2
$14.3M Buy
37,377
+225
+0.6% +$81.1K 0.14% 140
2025
Q1
$12.8M Hold
37,152
0.14% 140
2024
Q4
$11.2M Sell
37,152
-3,781
-9% -$1.32M 0.11% 174
2024
Q3
$16.6M Sell
40,933
-183
-0.4% -$67K 0.16% 119
2024
Q2
$13.2M Sell
41,116
-142
-0.3% -$46.1K 0.13% 144
2024
Q1
$13.8M Sell
41,258
-719
-2% -$220K 0.15% 134
2023
Q4
$11.4M Sell
41,977
-1,156
-3% -$286K 0.14% 149
2023
Q3
$10.6M Buy
43,133
+1,323
+3% +$362K 0.14% 139
2023
Q2
$12.7M Buy
41,810
+90
+0.2% +$25K 0.17% 120
2023
Q1
$11M Sell
41,720
-435
-1% -$110K 0.17% 123
2022
Q4
$10.1M Sell
42,155
-25
-0.1% -$5.6K 0.17% 133
2022
Q3
$7.75M Buy
42,180
+333
+0.8% +$66.3K 0.14% 153
2022
Q2
$7.03M Hold
41,847
0.12% 173
2022
Q1
$10.5M Buy
41,847
+6,181
+17% +$1.55M 0.16% 126
2021
Q4
$9.16M Sell
35,666
-382
-1% -$93.5K 0.17% 117
2021
Q3
$8.75M Sell
36,048
-84
-0.2% -$20.5K 0.18% 109
2021
Q2
$7.47M Buy
36,132
+6,037
+20% +$1.23M 0.15% 138
2021
Q1
$5.67M Buy
30,095
+3,972
+15% +$700K 0.15% 134
2020
Q4
$4.3M Buy
26,123
+3,842
+17% +$562K 0.14% 143
2020
Q3
$2.78M Buy
22,281
+2,330
+12% +$288K 0.12% 166
2020
Q2
$1.94M Sell
19,951
-7,596
-28% -$790K 0.1% 202
2020
Q1
$2.51M Sell
27,547
-1,037
-4% -$134K 0.11% 174
2019
Q4
$4.22M Sell
28,584
-1,375
-5% -$185K 0.15% 154
2019
Q3
$3.61M Buy
29,959
+9,925
+50% +$1.28M 0.13% 171
2019
Q2
$2.71M Buy
20,034
+1,471
+8% +$186K 0.15% 146
2019
Q1
$2.42M Buy
18,563
+2,488
+15% +$334K 0.16% 146
2018
Q4
$2M Buy
16,075
+1,348
+9% +$181K 0.16% 138
2018
Q3
$2.05M Buy
14,727
+2,196
+18% +$273K 0.16% 144
2018
Q2
$1.29M Buy
12,531
+3,834
+44% +$388K 0.12% 179
2018
Q1
$844K Buy
8,697
+656
+8% +$63.6K 0.12% 184
2017
Q4
$706K Sell
8,041
-80
-1% -$6.43K 0.11% 204
2017
Q3
$646K Sell
8,121
-150
-2% -$12.1K 0.11% 217
2017
Q2
$721K Buy
8,271
+2,056
+33% +$174K 0.13% 184
2017
Q1
$553K Buy
6,215
+2,240
+56% +$187K 0.14% 173
2016
Q4
$294K Buy
+3,975
New +$298K 0.14% 195

Other funds holding HCA

IFM Investors's HCA Position: Q2 2026 in Review

IFM Investors increased its HCA Healthcare (HCA) stake by 6.9% in Q2 2026, buying an estimated $980K and bringing the position to 35,839 shares worth $14M. The position accounts for 0.09% of the portfolio, ranked #204.

IFM Investors first reported a position in HCA in Q4 2016 and has held it in 39 quarters since. The position peaked at $16.6M in Q3 2024. 342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • IFM Investors held 35,839 shares of HCA Healthcare worth $14M as of Q2 2026.
  • IFM Investors bought 2,319 HCA Healthcare shares in Q2 2026, an estimated $980K.
  • HCA Healthcare made up 0.09% of IFM Investors's portfolio in Q2 2026, its #204 holding.
  • IFM Investors first reported a position in HCA Healthcare in Q4 2016 and has held it in 39 quarters since.
  • IFM Investors's HCA Healthcare position peaked at $16.6M in Q3 2024.
  • 342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.